Balaji Prasad analyst

Currently out of the existing stock ratings of Balaji Prasad, 20 are a SELL (9.52%), 29 are a HOLD (13.81%), 161 are a BUY (76.67%).

Balaji Prasad

Work Performance Price Targets & Ratings Chart

Analyst Balaji Prasad, carries an average stock price target met ratio of 57.02% that have a potential upside of 27.92% achieved within 340 days. Previously, Balaji Prasad worked at BARCLAYS.

Balaji Prasad’s has documented 421 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Energy sectors.

Most recent stock forecast was given on EOLS, Evolus at 05-Mar-2025.

Wall Street Analyst Balaji Prasad

Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.

Average potential price target upside

BHC Bausch Health Companies CHRS Coherus BioSciences ELAN Elanco Animal Health ENDP Endo International PLC EOLS Evolus IDXX IDEXX Laboratories JAZZ Jazz Pharmaceuticals PLC LGND Ligand Pharmaceuticals PAHC Phibro Animal Health PCRX Pacira Pharmaceuticals RDY Dr. Reddy’s Laboratories Ltd ADR RVNC Revance The TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis VTRS Viatris AMAG AMAG Pharmaceuticals AMRX Amneal Pharmaceuticals, Common Stock CVET Covetrus MNK Mallinckrodt plc PYPD PolyPid RVLP RVL Pharmaceuticals PLC ALVO Alvotech TARS Tarsus Pharmaceuticals OGN Organon KIN Kindred Biosciences AM Antero Midstream Partners LP CVE Cenovus Energy MNLO Menlo Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Aug-2022

$9

$3.31 (58.17%)

$10

5 months 5 days ago
(27-Apr-2026)

12/26 (46.15%)

$3.42 (61.29%)

247

Hold Since 25-Feb-2026

$7

$1.31 (23.02%)

$7

6 months 1 days ago
(31-Mar-2026)

4/8 (50%)

$1.6 (29.63%)

134

Hold Since 25-Jul-2024

$8

$2.31 (40.60%)

$7

8 months 25 days ago
(07-Jan-2026)

1/2 (50%)

$0.1 (1.27%)

53

Hold Since 10-Jul-2024

$8

$2.31 (40.60%)

1 years 4 months 27 days ago
(05-May-2025)

2/2 (100%)

$3.07 (62.27%)

86

Hold Since 22-Jan-2021

$3

$-2.69 (-47.28%)

$9

2 years 2 months ago
(02-Aug-2024)

12/15 (80%)

$-2.63 (-46.71%)

185

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?